Skip to main content

Tildrakizumab for Plaque Psoriasis User Reviews

Brand names: Ilumya

Rating: 8.7

Tildrakizumab has an average rating of 8.7 out of 10 from a total of 3 reviews for the treatment of plaque psoriasis. 100% of reviewers reported a positive experience, while 0% reported a negative experience.

10
0%
9
67%
8
33%
7
0%
6
0%
5
0%
4
0%
3
0%
2
0%
1
0%
  • Bet...
  • Taken for 1 to 6 months
  • October 4, 2019

"I had psoriasis on both legs from knees down, both elbows, hands, and scalp. After the second injection of Ilumya, I am now 90% clear with no side effects. I have tried Otezla, but after a year, it stopped working. All the creams, etc., had no effect, so here’s hoping that Ilumya is my miracle."

9 / 10
Was this helpful?YesNo
16 Report
  • Dus...
  • Taken for 1 to 2 years
  • October 17, 2023

"I have had moderate to severe plaque psoriasis for almost 15 years. Methotrexate treatment was successful for many years then eventually became less effective. My doctor then got me on Ilumya over a year ago and for the majority of the year, I have been completely clear. There was one outbreak that happened for a month or so and I believe this was due to a partially defective batch of the drug. It is amazing only needing a quick injection every 12 weeks! So far so good."

9 / 10
Was this helpful?YesNo
1 Report
  • Aaa...
  • Taken for 6 months to 1 year
  • April 16, 2025

"Ilumya helps with the itching and most of my lesions are gone, with just a little bit of the skin discolorations yet to fade. Now if we could get the amount what is left for Sam/Sue Sr. Citizen to pay (after medication charge and what is paid by insurance) to be lower and more budget friendly, many more patients could be served by this wonderful drug!"

8 / 10
Was this helpful?YesNo
0 Report

Frequently asked questions

Are you taking this medicine?

Your review helps others make informed decisions.
Write a review
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.